Now showing 1 - 7 of 7
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Special Conditions in Venous Thrombembolism - Case Series
    (Macedonian Academy of Sciences and Arts/Walter de Gruyter GmbH, 2019-10-01)
    ;
    ;
    ;
    Klincheva, Milka
    ;
    Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is a preventable cause of in-hospital death, and one of the most prevalent vascular diseases. There is a lack of knowledge with regards to contemporary presentation, management, and outcomes of patients with VTE. Many clinically important subgroups (including the elderly, those with recent bleeding, renal insufficiency, disseminated malignancy or pregnant patients) have been under-represented in randomized clinical trials. We still need information from real life data (as example RIETE). The paper presents case series with VTE in special conditions, including cancer associated thrombosis, malignant homeopathies, as well in high risk population.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Impact of anthropometric factors on outcomes in atrial fibrillation patients: analysis on 10 220 patients from the European Society of Cardiology (ESC)-European Heart Rhythm Association (EHRA) EurObservational Research Programme on Atrial Fibrillation (EORP-AF) general long-term registry
    (Oxford University Press (OUP), 2022-06-07)
    Boriani, Giuseppe
    ;
    Vitolo, Marco
    ;
    Malavasi, Vincenzo L
    ;
    Proietti, Marco
    ;
    Fantecchi, Elisa
    Abstract Aim To investigate the association of anthropometric parameters [height, weight, body mass index (BMI), body surface area (BSA), and lean body mass (LBM)] with outcomes in atrial fibrillation (AF). Methods and results Ten-thousand two-hundred twenty patients were enrolled [40.3% females, median age 70 (62–77) years, followed for 728 (interquartile range 653–745) days]. Sex-specific tertiles were considered for the five anthropometric variables. At the end of follow-up, survival free from all-cause death was worse in the lowest tertiles for all the anthropometric variables analyzed. On multivariable Cox regression analysis, an independent association with all-cause death was found for the lowest vs. middle tertile when body weight (hazard ratio [HR] 1.66, 95%CI 1.23–2.23), BMI (HR 1.65, 95%CI 1.23–2.21), and BSA (HR 1.49, 95%CI 1.11–2.01) were analysed in female sex, as well as for body weight in male patients (HR 1.61, 95%CI 1.25–2.07). Conversely, the risk of MACE was lower for the highest tertile (vs. middle tertile) of BSA and LBM in males and for the highest tertile of weight and BSA in female patients. A higher occurrence of haemorrhagic events was found for female patients in the lowest tertile of height [odds ratio (OR) 1.90, 95%CI 1.23–2.94] and LBM (OR 2.13, 95%CI 1.40–3.26). Conclusions In AF patients height, weight, BMI, BSA, and LBM were associated with clinical outcomes, with all-cause death being higher for patients presenting lower values of these variables, i.e. in the lowest tertiles of distribution. The anthropometric variables independently associated with other outcomes were also different between male and female subjects.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Special Conditions in Venous Thrombembolism – Case Series
    (Macedonian Academy of Sciences and Arts, 2019-10-01)
    ;
    ;
    ;
    Klincheva, Milka
    ;
    Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is a preventable cause of in-hospital death, and one of the most prevalent vascular diseases. There is a lack of knowledge with regards to contemporary presentation, management, and outcomes of patients with VTE. Many clinically important subgroups (including the elderly, those with recent bleeding, renal insufficiency, disseminated malignancy or pregnant patients) have been under-represented in randomized clinical trials. We still need information from real life data (as example RIETE). The paper presents case series with VTE in special conditions, including cancer associated thrombosis, malignant homeopathies, as well in high risk population.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Can We Use Khorana Score in Patients with Non-Active Carcinoma?
    (Macedonian Society of Cardiology, 2019-04)
    ;
    ;
    ;
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Differential Diagnostic Approach between Pulmonary Embolism and Acute Coronary Syndrome
    (Macedonian Society of Cardiology, 2019-04)
    ;
    ;
    ;
    Jovanovski, Mario
    ;
  • Some of the metrics are blocked by your 
    Item type:Publication,
    CLINICAL ASPECTS OF CANCER-ASSOCIATED THROMBOSIS
    (2023)
    ;
    Active cancer accounts for 20% of the total incidence of venous thrombembolism (VTE), a condition called cancer-associated thrombosis (CAT) . Cancer is the leading cause of death in patients with VTE and vice versa. Risk factors for VTE can be classified into three groups: patient-related, cancer-related, and treatment-related. This review contains the most relevant, up to date, randomized controlled studies for carcinoma-associated thrombosis, pathogenesis and risk factors for CAT, risk assessment models, and most importantly, recommendation for thromboprophylaxis of patients with carcinoma, treatment of patients with CAT for both, hospitalized and outpatients, and secondary prevention of VTE, comparing efficacy and safety of low-molecular weight heparin (LMWH) to direct oral anticoagulans (DOAC), balancing between the risk of recurrent VTE and major bleeding.
  • Some of the metrics are blocked by your 
    Item type:Publication,